Informative risk-benefit analysis and effective risk management are essential to the ultimate commercial success of your product. We are a leader in developing statistically rigorous, scientifically valid risk-benefit assessment studies that can be used to demonstrate the level of risk patients and other decision makers are willing to accept to achieve the benefits provided by your product.
Risk-Benefit Modeling
Systematically quantify the relative importance of risks and benefits to demonstrate the net benefits of treatment
Risk-Benefit Tradeoffs
Quantify patients’ maximum acceptable risk for specific therapeutic benefits
To illustrate, below is an example of maximum acceptable risk estimates for various levels of treatment benefits indicating that patients' risk tolerance increases as benefit levels increase.
SENIOR LEADERSHIP
A Brett Hauber, PhD Global Head of Health Preference Assessment and Market Access
